Engin Yapici
@enginyapici.bsky.social
Drug discovery scientist writing about bioassays, AI in biotech, and the messy, fascinating process of turning biology into medicine.
Definitely an ambitious project. But how will virtual cells handle protein-level effects that are critical in biologics, like glycosylation, secretion, or conformational changes? These aren’t in transcriptomic data. Will future models include assays that capture them?
May 25, 2025 at 7:44 PM
Definitely an ambitious project. But how will virtual cells handle protein-level effects that are critical in biologics, like glycosylation, secretion, or conformational changes? These aren’t in transcriptomic data. Will future models include assays that capture them?